Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Westera

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|February 1, 1989
Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11A Smith, R Waibel, G Westera, et al.
European Journal of Nuclear Medicine|August 1, 1980
A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and 201Tl-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imagingG Westera, E E van der Wall, G A Heidendal, et al.
Nuklearmedizin. Nuclear Medicine|February 1, 1990
The influence of lactate and dipyridamole on myocardial fatty acid metabolism in man, traced with 123I-17-iodoheptadecanoic acidC M Duwel, F C Visser, M J van Eenige, et al.
European Heart Journal|August 1, 1985
Kinetics of radioiodinated heptadecanoic acid and metabolites in the normal and ischaemic canine heartF C Visser, M J van Eenige, G Westera, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Synthesis and electrophysiological studies of a novel epibatidine analogueJ E Spang, J T Patt, S Bertrand, et al.
Chemistry & Biology|July 25, 2000
Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptorsJ E Spang, S Bertrand, G Westera, et al.
FEBS Letters|June 8, 1999
Neuronal nAChR stereoselectivity to non-natural epibatidine derivativesS Bertrand, J T Patt, J E Spang, et al.
European Journal of Nuclear Medicine|October 1, 1980
I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary studyE E van der Wall, G A Heidendal, W den Hollander, et al.
Postgraduate Medical Journal|January 1, 1983
Myocardial scintigraphy with 123I-labelled heptadecanoic acid in patients with unstable angina pectorisE E van der Wall, G A Heidendal, W den Hollander, et al.
European Journal of Nuclear Medicine|January 1, 1981
Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectorisE E van der Wall, G A Heidendal, W den Hollander, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|February 1, 1989
Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11A Smith, R Waibel, G Westera, et al.
European Journal of Nuclear Medicine|August 1, 1980
A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and 201Tl-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imagingG Westera, E E van der Wall, G A Heidendal, et al.
Nuklearmedizin. Nuclear Medicine|February 1, 1990
The influence of lactate and dipyridamole on myocardial fatty acid metabolism in man, traced with 123I-17-iodoheptadecanoic acidC M Duwel, F C Visser, M J van Eenige, et al.
European Heart Journal|August 1, 1985
Kinetics of radioiodinated heptadecanoic acid and metabolites in the normal and ischaemic canine heartF C Visser, M J van Eenige, G Westera, et al.
Journal of Receptor and Signal Transduction Research|March 11, 1999
Synthesis and electrophysiological studies of a novel epibatidine analogueJ E Spang, J T Patt, S Bertrand, et al.
Chemistry & Biology|July 25, 2000
Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptorsJ E Spang, S Bertrand, G Westera, et al.
FEBS Letters|June 8, 1999
Neuronal nAChR stereoselectivity to non-natural epibatidine derivativesS Bertrand, J T Patt, J E Spang, et al.
European Journal of Nuclear Medicine|October 1, 1980
I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary studyE E van der Wall, G A Heidendal, W den Hollander, et al.
Postgraduate Medical Journal|January 1, 1983
Myocardial scintigraphy with 123I-labelled heptadecanoic acid in patients with unstable angina pectorisE E van der Wall, G A Heidendal, W den Hollander, et al.
European Journal of Nuclear Medicine|January 1, 1981
Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectorisE E van der Wall, G A Heidendal, W den Hollander, et al.
Pageof 6